Evaluation of Diacare (Herbal Anti diabetic drug) on hyperglycemia in diabetic patient type2: clinical trial double blind

Therapeutic effects of Diacare herbal medicine on blood sugar control in type 2 diabetic patients

A double-blind clinical trial, two treatment groups and a placebo in parallel will be a study on 80 patients. For randomization, we will use the method of permutation blocks with several 6 blocks using Random allocation software.

Patients with type 2 diabetes referred to the partner medical centers in the project are divided into A and B groups. The therapeutic effects of Diacare on clinical and laboratory indicators of type 2 diabetes will be evaluated. The study will be blinded at the level of outcome assessor, physician, and statistical analyst. Location: Fasa University of Medical Sciences

inclusion criteria 1. Diagnosis by a doctor 2. Age from 40 to 60 years 3. At least two years of history of type 2 diabetes 4. Having informed and written consent to participate in the study Criteria for non-entry 1. Patients with side infections 2. Cardiovascular patients 3. Pregnancy and lactation 4. The disagreement of the physician directly responsible for the patient 5. Food and health allergies Community Verified icon

Divide patients into two similar groups A and B. The treatment group of capsules containing Diacare drug and the placebo group of capsules containing popcorn flour, every 12 hours. By introducing the patient's plan and justification, written consent is received.

HBA1C Changes

Patients with type 2 diabetes, after diagnosis and confirmation of admission requirements, enter the study with personal consent. For patients, the study code along with the relevant information (medication regimen, age and sex, severity of disease and severity of symptoms) is provided by the expert to the patient. The relevant expert divides the patients into two similar groups based on the treatment regimen, age group, gender, severity of the disease and symptoms, and randomly divides one group into group A and one group into group B using the patient code numbers. Give. For randomization, the permutation block method with the number of blocks of 6 is done using Random allocation software.

after fulfillment of inclusion criteria, the physician will be prescribe A (the drug) or B (placebo) according to the randomized sheet. the prescription will be dispensed in the same package. healthcare givers will be unaware about coding dedicated to every patient. The results of the two groups under the headings of groups A and B will be delivered to the statistical analyzer.

Some of the information obtained will be available based on changes in initial outcomes

Start of access period 6 months after production of results

People engaged in research in medical universities of the country

The methods and data contained in this clinical trial should be used solely to advance similar projects. It is also necessary to mention the research center of this study (Fasa University of Medical Sciences) if the information is used

Amin Dakhili Ardestani, Email Address: Amindakhiliardestani@yahoo.com Contact Number: 09228584505 Address: Fasa University, Ibn Sina Square, Fasa University of Medical Sciences and Health Services

1. Contacting the general respondent of study 2. Sending his formal request to the respondent 3. The application form in the University Research Council 4. In case of a positive response from the council, it will be provided to the applicant in accordance with the ethical principles. 5. The total duration of the process is 20 days.